Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Advanced Technologies for Antigen Identification
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research

Cancer Immunology Research

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Advanced Technologies for Antigen Identification
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

The AACR remains fully committed to supporting publishing operations throughout this challenging time, while still remaining flexible and supportive of the author, reviewer, and editor communities that we serve. If you have any questions or concerns, please reach out to a member of the AACR publishing staff.
Please visit the COVID-19 & Cancer Resource Center where COVID-related content is freely available.

 

We welcome pre-submission inquiries! Simply email the editors at cancerimmunolres@aacr.org. Learn more.

  • CIR Current Cover
    Read the April issue!
    About the cover: The study by Fu,et al, reveals that inhibition of Dgka has dual effects on T-cell invigoration. Read more in the article. Original image from Fig. 7A. Artwork by Lewis Long.
  • Gut Microbiota and Antitumor Immunity
    Cancer Immunology at the Crossroads
    Gut Microbiota and Antitumor Immunity: Potential Mechanisms for Clinical Effect, Erez N. Baruch, et al.
  • In the Spotlight
    In the Spotlight
    HIF1α or HIF2α: Enhancing CD8+ T-cell Fitness for Antitumor Immunity, Jin Chen.
  • 1
  • 2
  • 3

From the Current Issue

  • What We're Reading
    A Sampling of Highlights from the Literature
    Cancer Immunol Res April 1 2021 9 (4) 363-363;

  • Research Articles | AuthorChoice
    Modified Hypoxia-Inducible Factor Expression in CD8+ T Cells Increases Antitumor Efficacy
    Pedro Veliça, Pedro P. Cunha, Nikola Vojnovic, Iosifina Petrina Foskolou, David Bargiela, Milos Gojkovic, Helene Rundqvist and Randall S. Johnson
    Cancer Immunol Res April 1 2021 9 (4) 401-414; DOI:10.1158/2326-6066.CIR-20-0561

    In this study, ectopic expression of FIH-insensitive HIF2α enhances human CD8+ T-cell cytolytic function in vitro and in a xenograft model. Modifying HIF expression may provide a way to enhance the antitumor efficacy of adoptive T-cell therapy.

  • Research Articles
    Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer
    Gang Xin, Yao Chen, Paytsar Topchyan, Moujtaba Y. Kasmani, Robert Burns, Peter J. Volberding, Xiaopeng Wu, Alexandra Cohn, Yiliang Chen, Chien-Wei Lin, Ping-Chih Ho, Roy Silverstein, Michael B. Dwinell and Weiguo Cui
    Cancer Immunol Res April 1 2021 9 (4) 454-469; DOI:10.1158/2326-6066.CIR-20-0433

    Myeloid-derived suppressor cells (MDSC) are a barrier to successful anti–PD-L1 therapy. The authors show that PIM1 facilitates CD36-mediated fatty acid uptake via the PPARγ pathway, promoting MDSC immunosuppressive activity, and that PIM1 inhibition overcomes resistance to anti–PD-L1 therapy.

  • Research Articles
    Modifications to the Framework Regions Eliminate Chimeric Antigen Receptor Tonic Signaling
    Elisa Landoni, Giovanni Fucá, Jian Wang, Venkat R. Chirasani, Zhiyuan Yao, Elena Dukhovlinova, Soldano Ferrone, Barbara Savoldo, Lee K. Hong, Peishun Shou, Silvia Musio, Francesco Padelli, Gaetano Finocchiaro, Miriam Droste, Brian Kuhlman, Abdijapar Shamshiev, Serena Pellegatta, Nikolay V. Dokholyan and Gianpietro Dotti
    Cancer Immunol Res April 1 2021 9 (4) 441-453; DOI:10.1158/2326-6066.CIR-20-0451

    Structural analysis demonstrates that the instability of the scFv causes CAR self-aggregation and tonic signaling. Amino acid substitutions or humanization of the framework regions abrogates the tonic signaling and enhances the functionality of CAR-T cells.

OnlineFirst Articles

  • IR700-VLPs induce long lasting anti-tumor immunity
    Rhonda C Kines, et al.
  • Myeloma-Derived Galectin-1 Interacts with MDSC CD304
    Ji-Young Lim, et al.
  • CD49a/CD49b Integrins Affect CD8+ T-cell Function in Tumors
    Marit M. Melssen, et al.
  • Exercise training improves antitumor immunity
    Igor L Gomes-Santos, et al.
Load more

Trending - Altmetric

No Altmetric data available.
Advertisement

Back to top
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement